Letter Professor Michael Reese Co-chairman, BMA medical academic staff committee: Further to your leading article “Splitting the Atom” (July 12), warnings from the Royal College of Radiologists and the British Nuclear Medicine Society on the risks of leaving Euratom must not be ignored. Radioactive isotopes play a vital role in diagnosing and treating cancer in the UK. While we can purchase isotopes from a small number of countries outside Euratom the supply will be less reliable and more costly. Because of how these isotopes decay, having a supply close to the point of use is critical for medical investigation and treatment. Euratom also underpins UK research and radiation safety in the nuclear industry. International co-operation and free movement of researchers is critical. Successive governments have recognised this, but we risk sacrificing this competitive advantage, which is to the benefit of patients.

Times 17th July 2017 read more »


Published: 17 July 2017